761197

544666

GKSL

img img img img
No Data Available

Gujarat Kidney N Sup Sp L Share Price Update

GUJARAT KIDNEY N SUP SP L made its market debut on 2025-12-30 and is currently trading at ₹143.33, up by ₹0.11 from its previous close. Today's session has seen the stock move between ₹140.91 and ₹146.49.

Gujarat Kidney N Sup Sp L performance

Today’s low Today’s high
₹ 140.91 ₹ 146.49
₹ 143.33
52 week low 52 week high
₹ 98.36 ₹ 147.80
₹ 143.33
Open Price ₹ 144.95
Prev. Close ₹ 143.21
Volume (Shares) 864186.00
Total traded value ₹ 1238.63
Upper Circuit ₹ 171.85
Lower Circuit ₹ 114.57
info

Investment Returns

Over 1 Month 27.18% Over 3 Months 26.25% Over 6 Months 36.99% Over 1 Year 0.00%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Gujarat Kidney N Sup Sp L fundamentals


  • Market cap (Cr) 1,130.10
  • P/E Ratio (TTM) 115.36
  • Beta 0.47
  • Book Value / share 35.82
  • Return on equity 16.70%
  • EPS (TTM) 1.24
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 2.33
info icon alternate text
  • Market cap (Cr) 1,138.90
  • P/E Ratio (TTM) 115.36
  • Beta 0.41
  • Book Value / share 35.82
  • Return on equity 16.70%
  • EPS (TTM) 1.24
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 2.33
info icon alternate text

Gujarat Kidney N Sup Sp L Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars DEC 2025 (Values in Cr)
Revenue 9.76
Operating Expense 6.63
Net Profit 2.33
Net Profit Margin (%) 23.87
Earnings Per Share (EPS) 0.41
EBITDA 4.17
Effective Tax Rate (%) 26.26
Particulars SEP 2025 (Values in Cr)
Revenue 9.64
Operating Expense 6.53
Net Profit 2.30
Net Profit Margin (%) 23.85
Earnings Per Share (EPS) 0.40
EBITDA 4.10
Effective Tax Rate (%) 26.28
Particulars JUN 2025 (Values in Cr)
Revenue 11.45
Operating Expense 6.05
Net Profit 3.90
Net Profit Margin (%) 34.06
Earnings Per Share (EPS) 0.69
EBITDA 6.33
Effective Tax Rate (%) 27.77
Particulars MAR 2025 (Values in Cr)
Revenue 8.02
Operating Expense 0.00
Net Profit 1.26
Net Profit Margin (%) 15.71
Earnings Per Share (EPS) 0.22
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars DEC 2024 (Values in Cr)
Revenue 8.51
Operating Expense 5.47
Net Profit 2.21
Net Profit Margin (%) 25.96
Earnings Per Share (EPS) 0.46
EBITDA 3.83
Effective Tax Rate (%) 27.77
Particulars MAR 2025 (Values in Cr)
Revenue 35.17
Operating Expense 23.18
Net Profit 9.11
Net Profit Margin (%) 25.90
Earnings Per Share (EPS) 1.79
EBITDA 15.55
Effective Tax Rate (%) 24.71
Particulars MAR 2025 (Values in Cr)
Book Value / Share 4.56
ROE % 51.71
ROCE % 51.95
Total Debt to Total Equity 0.39
EBITDA Margin 41.53
Particulars MAR 2024 (Values in Cr)
Book Value / Share 17.41
ROE % 21.13
ROCE % 18.84
Total Debt to Total Equity 0.53
EBITDA Margin 41.06
Particulars MAR 2023 (Values in Cr)
Book Value / Share 3.70
ROE % -2.70
ROCE % -2.70
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 91.42
ROE % 16.70
ROCE % 19.02
Total Debt to Total Equity 0.17
EBITDA Margin 31.53
Particulars MAR 2023 (Values in Cr)
Book Value / Share 18.74
ROE % -2.70
ROCE % -2.70
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 2.80
Total Assets 55.34
Total Liabilities 55.34
Total Equity 27.12
Share Outstanding 5
Price to Book Ratio 0.00
Return on Assets (%) 17.00
Return on Capital (%) 30.36
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.17
Total Assets 20.52
Total Liabilities 20.52
Total Equity 10.80
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 8.35
Return on Capital (%) 13.45
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 3.86
Total Liabilities 3.86
Total Equity 0.37
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) -0.16
Return on Capital (%) -1.67
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.17
Total Assets 16.81
Total Liabilities 16.81
Total Equity 10.89
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 8.64
Return on Capital (%) 11.32
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 3.87
Total Liabilities 3.87
Total Equity 0.37
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) -0.16
Return on Capital (%) -1.65
Particulars MAR 2025 (Values in Cr)
Net Income 9.49
Cash from Operations 16.37
Cash from Investing -18.14
Cash from Financing 6.16
Net change in Cash 1.62
Free Cash Flow 27.48
Particulars MAR 2024 (Values in Cr)
Net Income 1.71
Cash from Operations 1.38
Cash from Investing 0.22
Cash from Financing -0.46
Net change in Cash 0.96
Free Cash Flow 1.38
Particulars MAR 2023 (Values in Cr)
Net Income 0.00
Cash from Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 0.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 8021.10 63.49 12.69 115331.11 6680.00 8249.95
FORTIS MALAR HOSPITALS LIMITED 52.81 23.90 2.88 98.98 40.75 78.80
SHREE PACETRONIX LTD. 127.40 19.22 2.81 47.77 66.10 283.15
TRANSGENE BIOTEK LTD. 3.14 0.00 2.58 23.79 1.83 5.26
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 8021.10 79.41 12.38 115331.11 6680.00 8249.95
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 38.48 0.00 -11.18 28.74 30.30 57.48
KOVAI MEDICAL CENTER & HO 5360.90 24.87 4.92 5864.82 5010.00 6725.00

Gujarat Kidney N Sup Sp L shareholding pattern

Holding
23.1%
71.45%
4.88%
0.56%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Gujarat Kidney N Sup Sp L Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
143.33 0.08 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 140.20
  • 26 Days 126.00
  • 10 Days 136.30
  • 50 Days 118.80
  • 12 Days 134.70
  • 100 Days 110.80
  • 20 Days 129.10
  • 200 Days 110.80
140.65 PIVOT
First Support 137.56 First Resistance 146.31 Second Support 131.90 Second Resistance 149.40 Third Support 128.81 Third Resistance 155.06
RSI 74.38 ADX 63.90 MACD 8.62 Williams % R -13.46 Commodity Channel Index (CCI) 90.09
Date 2026-05-18 Week 569038.00 Same Day 262026.00 Month 489621.00
1 Year 0.48 3 Year 0.46
Over 1 Month
27.18% down
Over 1 Year
0.00% down
Over 3 Months
26.25% down
Over 3 Years
0.00% down
Over 6 Months
36.99% down
Over 5 Years
0.00% down

Gujarat Kidney N Sup Sp L Corporate Actions

Top Gainers

Top Losers

Gujarat Kidney N Sup Sp L Share Price

Gujarat Kidney And Super Speciality Limited was incorporated under the name and style of Vihaan Medicare Private Limited', a private limited company, dated December 20, 2019 issued by the Registrar of Companies, Central Registration Centre. Subsequently, the Company name was changed to Gujarat Kidney and Super Speciality Private Limited' and a fresh certificate of incorporation dated September 13, 2023 was issued by the Registrar of Companies, Gujarat at Ahmedabad. Further, Company' status was changed to a public limited company and the name of Company was changed to Gujarat Kidney and Super Speciality Limited' dated November 24, 2023 by the ROCs, Ahmedabad.

The Company operate a chain of mid-sized multispecialty healthcare institution and is engaged in providing comprehensive medical services, including inpatient and outpatient care, surgical procedures, diagnostic services, and emergency care. It is one of the regional healthcare companies located in the central region of state of Gujarat.

The Company categorize its healthcare services as secondary services (which are surgical services) and Tertiary Services (which are super speciality surgical services). The Hospital operates with a commitment to delivering high-quality healthcare through advanced medical technology and a team of highly skilled professionals.

The Company established and commenced the operations of its first hospital under the name of Gujarat Kidney Hospital' at Vadodara, Gujarat in 2014 and later on expanded the bed capacity from 15 to 65 in 2018, with the establishment of 5 sub-specialities in the Uro Department, viz., endourology, urologic oncology, paediatric urology, reconstructive urology, and laparoscopic urology at the Gujarat Kidney Hospital.

In 2019, it set up an in-house interventional cardiology department under the name of Gujarat Heart Care Unit' for offering invasive cardiology services. In 2021, carried out its first laparoscopic radical prostatectomy at the Gujarat Kidney Hospital. The Company commenced operations of its second hospital in Godhra, Gujarat in 2023, followed by carrying its first renal transplant and first Angiography in Godhra Hospital. The Company set up 3 super-speciality departments for cardiology, urology and nephrology at the Godhra Hospital in 2023-24.

In 2024, Company carried out its first retrograde intrarenal surgery (RIRS) at the Godhra Hospital. It acquired majority stake in Raj Palmland Hospital Private Limited, thereby making it the Subsidiary of the Company. In 2025, the Company has acquired Ashwini Medical Centre.

Company has filed a Draft Prospectus and is planning to make IPO of 2,20,00,000 equity shares of face value of Rs 2/- each through fresh issue.

Parent organization Indian Private
NSE symbol GKSL
Founded 2019
stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Gujarat Kidney & Super Speciality Ltd?

Answer Field

Gujarat Kidney & Super Speciality Ltd share price is for NSE ₹ 143.33 & for BSE ₹ 144.45 as on May 19 2026 03:30 PM.

What is the Market Cap of Gujarat Kidney & Super Speciality Ltd Share?

Answer Field

The market cap of Gujarat Kidney & Super Speciality Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on May 19 2026 03:30 PM.

What is the 52 Week High and Low of Gujarat Kidney & Super Speciality Ltd?

Answer Field

The 52 Week High and Low of Gujarat Kidney & Super Speciality Ltd for NSE is ₹ 147.80 and ₹ 98.36 and for BSE is ₹ 147.90 and ₹ 98.25.

What is 1 year return for Gujarat Kidney & Super Speciality Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the P/E Ratio of Gujarat Kidney & Super Speciality Ltd Share?

Answer Field

As on May 19 2026 03:30 PM the price-to-earnings (PE) ratio for Gujarat Kidney & Super Speciality Ltd share is 115.36.

What is the PB ratio of Gujarat Kidney & Super Speciality Ltd Share?

Answer Field

As on May 19 2026 03:30 PM, the price-to-book (PB) ratio for Gujarat Kidney & Super Speciality Ltd share is 35.82.

How to Buy Gujarat Kidney & Super Speciality Ltd Share?

Answer Field

You can trade in Gujarat Kidney & Super Speciality Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Gujarat Kidney & Super Speciality Ltd Share on Bajaj Broking App?

Answer Field

To buy Gujarat Kidney & Super Speciality Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Gujarat Kidney & Super Speciality Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|